SUSQUEHANNA INTERNATIONAL GROUP, LLP - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$31,000
-18.4%
23,352
-31.4%
0.00%
Q4 2018$38,000
-97.3%
34,038
-93.2%
0.00%
Q3 2018$1,385,000
+51.9%
501,665
+96.4%
0.00%
Q2 2018$912,000
+5.2%
255,400
-9.6%
0.00%
Q1 2018$867,000
-29.1%
282,368
+45.4%
0.00%
Q4 2017$1,223,000
+4.7%
194,226
+13.7%
0.00%
Q3 2017$1,168,000
-54.4%
170,800
-52.4%
0.00%
-100.0%
Q2 2017$2,561,000
+112.0%
359,200
+173.4%
0.00%0.0%
Q1 2017$1,208,000
+143.1%
131,400
+6.4%
0.00%
Q4 2016$497,000
+40.0%
123,453
+33.0%
0.00%
Q3 2016$355,000
+14.5%
92,800
+28.9%
0.00%
Q2 2016$310,000
-73.8%
72,017
-71.8%
0.00%
Q1 2016$1,184,000
-51.9%
255,611
+4.1%
0.00%
Q4 2015$2,463,000
-52.2%
245,544
-64.4%
0.00%
-100.0%
Q3 2015$5,151,000
-59.3%
690,498
+159.1%
0.00%
-60.0%
Q2 2015$12,645,000
+87.0%
266,541
+44.4%
0.01%
+25.0%
Q1 2015$6,762,000
+23.6%
184,544
+33.9%
0.00%
+33.3%
Q4 2014$5,472,000
+102.1%
137,778
+1.5%
0.00%
Q3 2014$2,707,000
+140.0%
135,684
+62.3%
0.00%
Q2 2014$1,128,000
+506.5%
83,618
+390.5%
0.00%
Q1 2014$186,000
+144.7%
17,046
+57.1%
0.00%
Q2 2013$76,00010,8480.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders